Stefanie Lechner

841 total citations
2 papers, 6 citations indexed

About

Stefanie Lechner is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Stefanie Lechner has authored 2 papers receiving a total of 6 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Genetics and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Stefanie Lechner's work include Lymphoma Diagnosis and Treatment (1 paper), Ubiquitin and proteasome pathways (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). Stefanie Lechner is often cited by papers focused on Lymphoma Diagnosis and Treatment (1 paper), Ubiquitin and proteasome pathways (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). Stefanie Lechner collaborates with scholars based in Germany. Stefanie Lechner's co-authors include E. Thiel, A. Georgii, Bertold Emmerich, W. E. Berdel, Thomas Friess, Peter Bruenker and Oliver Krieter and has published in prestigious journals such as Molecular Cancer Therapeutics and Annals of Hematology.

In The Last Decade

Stefanie Lechner

2 papers receiving 5 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefanie Lechner Germany	2	5	4	3	2	1	2	6
Juana Gil Herrera Spain	2	6 1.2×	3 0.8×	5 1.7×	1 0.5×	1 1.0×	4	9
Eva Minga Greece	2	4 0.8×	3 0.8×	5 1.7×		1 1.0×	2	7
James Laffan United Kingdom	2	5 1.0×	3 0.8×	4 1.3×			3	14
Lucía Zoppegno Argentina	2	3 0.6×	7 1.8×		3 1.5×		3	7
Spencer Henick Bachow United States	2	2 0.4×	6 1.5×	4 1.3×	4 2.0×	1 1.0×	2	9
Jacqueline Russo United States	2	3 0.6×	2 0.5×		1 0.5×		3	9
Alice Guerini Italy	2	4 0.8×	2 0.5×	3 1.0×			3	8
Elina Tsyvkin United States	3	5 1.0×	3 0.8×	1 0.3×	1 0.5×	2 2.0×	3	9
Laurence Bouillet France	2	5 1.0×	2 0.5×	2 0.7×		2 2.0×	3	8
Christine D Crider South Africa	1	6 1.2×	5 1.3×	2 0.7×	1 0.5×		2	6

Countries citing papers authored by Stefanie Lechner

Since Specialization

Citations

This map shows the geographic impact of Stefanie Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Lechner more than expected).

Fields of papers citing papers by Stefanie Lechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Lechner. The network helps show where Stefanie Lechner may publish in the future.

Co-authorship network of co-authors of Stefanie Lechner

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Lechner. A scholar is included among the top collaborators of Stefanie Lechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Lechner. Stefanie Lechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Friess, Thomas, et al.. (2015). Abstract C125: Preclinical pharmacodynamic biomarker and combination strategy of RG7386, a novel FAP-DR5 bispecific antibody for targeting solid tumors. Molecular Cancer Therapeutics. 14(12_Supplement_2). C125–C125. 1 indexed citations

2.

Emmerich, Bertold, et al.. (1983). Conversion of an IGM secreting immunocytoma in a high grade malignant lymphoma of immunoblastic type. Annals of Hematology. 46(2). 81–84. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact